Biohacking, our medicines of tomorrow?

[ad_1]

Biohacking, or participatory biology, is making its appearance to allow a much less heavy and invasive internal treatment for the human body. This new kind of medicine would never have been possible without years of research … Focus on the future of our medicines.

Thanks to research on the human body, which is becoming more and more precise, scientists are able to understand how the body actually works and are able to understand certain mechanisms, until now poorly known: such as role of bacteria in the balance of the body.

What is biohacking

Researchers realized a few years ago that bacteria found in the body, especially in the stomach, play an active role in keeping the body balanced and protecting it from infections and diseases. We mistakenly thought that only cells and DNA controlled the human body.

After this discovery, scientists came up with the idea of hack bacteria so that they become little soldiers infiltrated on behalf of the treatment. By directly hacking the bacteria, scientists hope to order them to go and treat a very precise part.

This revolution in the field of health, allows to offer targeted treatments and presenting well less danger to the patient. Indeed, it is its bacteria themselves that will fight the disease. This futuristic technique will surely disrupt the health field and drug treatments in particular.

What future for biohacking?

It is currently the MIT which takes up most of the research on biohacking, in collaboration with the Synlogic biopharmaceutical laboratory. They are developing a new class of drugs, “synthetic biotics”, which are actually bacteria whose genetic makeup has been modified to artificially redefine their mission in the human body.

In this way, bacteria are able to detect inflammations in the digestive system, which are responsible for certain more serious diseases, such as Crohn's disease for example. In the future, it will be possible to offer treatments that present no risk of danger and rejection for more fragile and sensitive patients.

[ad_2]